Recent Finacing
Recent Raise
Elstar Therapeutics develops antibody-based multi‑functional cancer immunotherapies via its UniTI platform that assembles up to four domains per molecule for dual-antigen targeting and innate/adaptive immune engagement with IgG-like manufacturing.
